CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks

Xinyuan Cao, Aiming Yang

Open source

DOI
10.2174/0115680266534378261027112811
Published
2026-10-28
Container
Current Topics in Medicinal Chemistry
Publisher
Bentham Science Publishers Ltd.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115680266534378261027112811,
  title = {CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks},
  author = {Xinyuan Cao and Aiming Yang},
  year = {2026},
  journal = {Current Topics in Medicinal Chemistry},
  doi = {10.2174/0115680266534378261027112811},
  url = {https://doi.org/10.2174/0115680266534378261027112811}
}

RIS

TY  - JOUR
TI  - CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks
AU  - Xinyuan Cao
AU  - Aiming Yang
PY  - 2026
JO  - Current Topics in Medicinal Chemistry
DO  - 10.2174/0115680266534378261027112811
UR  - https://doi.org/10.2174/0115680266534378261027112811
ER  - 

APA

Cao, X., & Yang, A. (2026). CAR-Engineered Immune Cells as Programmable Living Therapeutics: Cell Sources, Engineering Routes, and Translational Bottlenecks. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/0115680266534378261027112811

Source records